PRMT6 inhibitors promote fracture healing by modulating osteoclast glucose metabolism
IntroductionImpaired fracture healing remains a significant clinical challenge due to the complexity of the healing process. Osteoclasts, derived from monocytes, are pivotal in bone tissue reconstruction, yet no effective clinical tools exist to promot…